Optimizing the 1L Management of Advanced Renal Cell Carcinoma: Focus on the Evolving Evidence and Best Practices for ICI–TKI Combinations Authors: Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP; Virginia J. Seery, MSN, RN, ANP-BC, AOCNP; Neil J. Shah, MD
No hay comentarios:
Publicar un comentario